Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-22-020840

Options or other derivatives

  • President and CEO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Oliveto Joseph President and CEO 2022-03-21 Grant or award · Employee Stock Option Grant (right to buy) +500,000 500,000 D
Loading xslF345X03/doc4.xml…